Africa News Currents
SEE OTHER BRANDS

Your daily news update on Africa

Africa News Currents: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Currents.

Press releases published on September 2, 2025

MEXC’s Q2 Zero-Fee Strategy Delivers Record Growth in High-Demand Pairs

MEXC’s Q2 Zero-Fee Strategy Delivers Record Growth in High-Demand Pairs

VICTORIA, Seychelles, Sept. 02, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, demonstrated sharp market insight in Q2 2025 by launching zero-fee promotions for popular futures trading pairs. This strategy significantly reduced …

Fortuna to present at Mining Forum Americas 2025 in Colorado Springs, USA

Fortuna to present at Mining Forum Americas 2025 in Colorado Springs, USA

VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is pleased to announce that it will be attending Mining Forum Americas, which is being held at the Broadmoor Hotel …

Novaremed Announces Completion of All Patient Visits in NIH-Funded Phase 2b Trial of Non-Opioid Nispomeben for Treating Chronic Pain Associated with Diabetic Peripheral Neuropathy

Novaremed Announces Completion of All Patient Visits in NIH-Funded Phase 2b Trial of Non-Opioid Nispomeben for Treating Chronic Pain Associated with Diabetic Peripheral Neuropathy

Last patient last visit (LPLV) was reached for the 127 adult and elderly patients enrolled into the 12-week placebo-controlled trial with nispomeben (NRD.E1)  Topline results are expected in November 2025 The trial builds on Phase 2a double-blind, …

FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA TRIAL EVALUATING CIT-013 IN RHEUMATOID ARTHRITIS

FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA TRIAL EVALUATING CIT-013 IN RHEUMATOID ARTHRITIS

Randomized multi-center study designed to assess the efficacy, safety, and tolerability of CIT-013 in patients with moderately active rheumatoid arthritis Oss, Netherlands – 2 September 2025 – Citryll, a biotech company pioneering a transformative approach …

Pharming Group appoints Kenneth Lynard as Chief Financial Officer

Pharming Group appoints Kenneth Lynard as Chief Financial Officer

Leiden, the Netherlands, September 2, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced the appointment of Kenneth Lynard as Chief Financial Officer (CFO), effective October 1, 2025. Mr. Lynard is a …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions